Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152576 | SCV000201833 | benign | not specified | 2014-09-09 | criteria provided, single submitter | clinical testing | Val4016Met in exon 61 of USH2A: This variant is not expected to have clinical si gnificance because it has been identified in 3.1% (6/186) of African chromosomes by the 1000 Genomes Project (rs138803855). It has also been identified in 0.3% (13/4404) of African American chromosomes by the NHLBI Exome sequencing project (http://evs.gs.washington.edu/EVS/), and the valine (Val) residue at position 4 016 is not conserved with squirrel, jerboa, prairie vole, rabbit, and aardvark h aving a methionine (Met). |
Eurofins Ntd Llc |
RCV000152576 | SCV000339954 | benign | not specified | 2016-04-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000884161 | SCV001027517 | likely benign | not provided | 2024-11-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000884161 | SCV001875191 | uncertain significance | not provided | 2021-08-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV004544386 | SCV004774218 | likely benign | USH2A-related disorder | 2023-11-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |